Beta O2

Beta-O2 technologies is developing the ßAir, a Bio-artificial Pancreas (BAP) intended to cure Type 1 diabetes (TID).The ßAir BAP provides a viable and safe environment for pancreatic IOL inside a subcutaneously implanted bioreactor. Consequently, they can thrive, function like native IOL thus providing the body with the two essential hormones at the correct ratio.

Using tech to replicate the pancreas